Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin‐1 Mediated Autoinflammatory Diseases https://t.co/0Ds0AvJPR6
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, an
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2022 – Dec 2023Where it's discussed
-
X / Twitter36 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions demonstrate a strong professional interest in the publication, with users expressing excitement and emphasizing the importance of the guidelines for diagnosing and managing severe autoinflammatory diseases. Words like 'excited' and mentions of 'clinical impact' highlight the perceived influence on future medical practices and research. The tone reflects both curiosity and recognition of the guidelines’ significance for improving patient outcomes.
The discussions generally reflect support or acknowledgement of the publication's importance, as seen in expressions like 'Excited to share' and calls for its relevance in clinical practice.
Many posts highlight curiosity and recognition of the topic's significance, indicating a high level of professional interest in the established guidelines.
Several discussions reference specific aspects such as diagnosis, management, and long-term monitoring, showing active engagement and deep consideration.
The overall tone suggests these guidelines could influence clinical practices, although explicit comments on implementation are limited, indicating a moderate impact perception.
Abstract in brief
- IL-1 mediated systemic autoinflammatory diseases like CAPS, TRAPS, MKD, and DIRA primarily affect young children, showing various organ involvement, and require effective treatment strategies due to their severe nature and poor prognosis if untreated.*
- A multidisciplinary task force was created to establish evidence-based guidelines for diagnosing and managing these diseases, using systematic reviews and expert consensus methods.*
- The task force created comprehensive recommendations, including 5 guiding principles, 14 statements on diagnosis, 10 on treatment, and 9 on long-term monitoring, aiming to improve patient outcomes through standardized care.*
Top posts
Most liked on X and BlueskyThe 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated perio… https://t.co/O6L2GQuS7f
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
Open Access UCL Research: The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases [BMJ] https://t.co/cX7xy9T8sJ
All mentions
Overview of Cryopyrin-Associated Periodic Syndromes and Autoinflammatory Diseases
Cryopyrin-associated periodic syndrome CAPS is a group of autoinflammatory conditions linked to the NLRP3 gene. This video explores their discovery, genetic basis, and clinical features, emphasizing the importance of…
Understanding CAPS Without Genetic Mutations and Treatment Options
If you have all the symptoms of cryopyrin-associated periodic syndrome CAPS but your genetic test didn't find a mutation, this video covers diagnosis and management strategies based on current guidelines and expert…
Open Access UCL Research: The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases [BMJ] https://t.co/cX7xy9T8sJ
Open Access UCL Research: The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases [...] https://t.co/WoIKRPgyh4
Cryopyrin‐Associated Periodic Syndromes, Tumour Necrosis Factor Receptor‐Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin‐1 Receptor Antagonist https://t.co/3LcOlsSfKB
RT @GranaTacha: The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleu…
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated perio… https://t.co/O6L2GQuS7f
RT @HellendeCarval4: The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Int…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin‐1 Mediated Autoinflammatory Diseases: Cryopyrin‐Associated Periodic Syndromes, Tumour Necrosis Factor Receptor‐Associated … https://t.co/mVS5op9Ma6
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
RT @ACR_Journals: Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consid…
Early view Special Article in Arthritis & Rheumatology: The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin‐1 Mediated Autoinflammatory Diseases https://t.co/0Ds0AvJPR6
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…
RT @hausmannMD: Excited to share the 2021 EULAR/ACR manuscript on the diagnosis, management and monitoring of IL-1 mediated #autoinflammato…